Llor Carl
Primary Care Research Institute Jordi Gol (IDIAP), Barcelona, Spain.
CIBER Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain.
Explor Res Clin Soc Pharm. 2025 Mar 11;18:100588. doi: 10.1016/j.rcsop.2025.100588. eCollection 2025 Jun.
Some papers emphasize adherence to antibiotic therapy, but a paradigm shift is needed. While nonadherence may impact chronic conditions, it has not been proven to affect community respiratory tract infections outside of tuberculosis. Respiratory infections, which account for most community antibiotic prescriptions, often involve inappropriate antibiotic use, even in developed countries, with up to 80 % of consultations resulting in prescriptions. Over-the-counter sales of antibiotics further exacerbate this issue. Research should explore whether stopping antibiotics after symptom resolution, rather than completing the full course, is feasible for non-severe infections. Shorter antibiotic courses have shown similar effectiveness with fewer side effects, aligning with the "shorter is better" principle. The idea that completing the entire antibiotic course prevents antimicrobial resistance remains unproven. Instead, longer exposure to antibiotics increases resistance. A patient-centered approach, focusing on outcomes, is essential for the future of antibiotic stewardship.
一些论文强调抗生素治疗的依从性,但需要转变思维模式。虽然不依从可能会影响慢性病,但尚未证明它会影响结核病以外的社区呼吸道感染。占大多数社区抗生素处方的呼吸道感染,即使在发达国家,也常常存在抗生素使用不当的情况,高达80%的会诊会开出抗生素处方。抗生素的非处方销售进一步加剧了这一问题。研究应探索对于非严重感染,在症状缓解后而非完成整个疗程就停用抗生素是否可行。较短疗程的抗生素已显示出相似的疗效且副作用更少,符合“越短越好”的原则。完成整个抗生素疗程可预防抗菌药物耐药性这一观点尚未得到证实。相反,更长时间使用抗生素会增加耐药性。以患者为中心、注重治疗结果的方法对抗生素管理的未来至关重要。